Sentences with phrase «in pharmaceutical patent»

In a pharmaceutical patent case, this would involve studying medicinal chemistry and pharmacology in considerable detail.

Paula Bremner — Sim, Lowman, Ashton & Mckay LLP — Paula specializes in pharmaceutical patent litigation and also has significant experience in trade - mark opposition matters.

Acting in pharmaceutical patent litigation for various well - known global brands involving blockbuster drugs.

Not exact matches

Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.

Generic pharmaceutical company Teva brought the suit against Pfizer hoping to produce a generic version of Viagra before Pfizer's patent was due to expire in 2014.

The firm is currently fielding both a federal lawsuit in Texas centering on Restasis as well as challenges from would - be competitors like Teva, Mylan Pharmaceuticals, and Akorn through the U.S. Patent and Trade Office's inter partes review (IPR) process.

The trend to inversions has been particularly strong in the pharmaceuticals sector, where many essentially U.S. - based or - focused companies have shifted their tax domicile to countries such as Ireland or the Netherlands, which have particularly generous corporate tax regimes, especially as regards monetizing patent - protected intellectual property.

Aside from the various scandals, patent protection for drugs that accounted for half of Bristol's pharmaceutical revenue was nearing an end or otherwise in jeopardy.

Jazz said in a filing that it did so in response to the overall takeover environment for pharma companies and in light of a patent litigation settlement that allows Hikma Pharmaceuticals to sell a generic version of Xyrem with Jazz receiving royalty payments on those sales.

Meanwhile, the patent term restoration provisions are likely to increase health care costs in Canada by delaying the availability of generic pharmaceuticals due to the extension in the term of protection for patented pharmaceuticals.

The material is largely silent on what Canada had to cede to Europe, especially in sectors such as dairy and patent protection for pharmaceuticals.

He represents pharmaceutical companies both large and small on a myriad of issues, as well as several universities in both patenting and licensing to outside investors.

MDMA was originally patented by pharmaceutical giant Merck in 1912, but it was never marketed and the patent lapsed.

It is hard to believe, for example, that Canada could not in the end find common ground with the US on some extension of patent protection for pharmaceuticals, since it was able to do so in the just - completed negotiations with the EU, or that an extension of the term of copyright protection from 50 to 70 years from the agreed baseline would have much if any real practical impact on Canada although it would be seen as a gain by the US given the heavy copyright portfolios of US entertainment companies, allowing them an additional period of time to exploit their copyrighted content.

When this happens, it could be a very difficult time for the pharmaceutical industry, which makes the time before the cliff all the more important as companies scramble to shore up their product lines and get their balance sheets in order before their products lose their patent protection [see also Is Your Biotech ETF A Leader Or Laggard?].

One of the few negatives on an otherwise fairly positive day of trading was the 5 % decline of Reckitt Benckiser, producers of a drug used to help get drug users off of Heroin called Suboxone, which acts as a replacement for the Class A. Reckitt's patent for Suboxone is due to expire in the relatively near future, so they have been trying to push doctors and other pharmaceutical vendors towards their film version of the drug, which is still under patent and will be for quite some time.

Analysts say that Trump might be interested in any number of proposals, like forcing Japan to import more US cars or agreements on patent laws that benefit US pharmaceutical companies.

In the meantime, established pharmaceutical companies can replicate the product awaiting review and then file a special 180 - day market exclusivity patent, which essentially steals the product and creates a temporary monopoly.

The jury still must consider what damages to award to Merck and its co-owner of the patents, Ionis Pharmaceuticals Inc., for past sales, Kenilworth, N.J. - based Merck said in a statement.

No. 3: The year of big pharma In the past five years, big cap pharmaceutical stocks have lagged biotech stocks because they've struggled to fill revenue gaps created by the patent cliff.

It's rare that it's tested in the USA because of the pharmaceutical industry's influence of dominating medicine with synthetic chemicals that can be patented.

For businesses that rely on innovation, like the UK's pharmaceutical industry, intellectual property — and more specifically, patents — are a crucial driving force in fuelling research and development.

Five years later, Gilead became the first pharmaceutical company to sign an agreement with the newly formed Medicines Patent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income counPatent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income counpatent - protected medicines so that they can be produced in generic form for low income countries.

4 March 1999, Author's Note: In keeping with the Patent Office's new policy, the first patent claiming EST sequences was issued on 6 October 1998 to Incyte PharmaceutPatent Office's new policy, the first patent claiming EST sequences was issued on 6 October 1998 to Incyte Pharmaceutpatent claiming EST sequences was issued on 6 October 1998 to Incyte Pharmaceuticals.

He has written extensively on pharmaceutical patents, parallel importation, antitrust law, commercialization and other uses of data, and the role of intellectual property policy in shaping these diverse areas.

In the last decade, Toronto companies held 61 % of U.S. patents granted to Canadian biotech firms, with the companies Aventis Pasteur, NPS Allelix Pharmaceuticals, Hemosol, Visible Genetics, and Spectral Diagnostics ranking in Canada's top fivIn the last decade, Toronto companies held 61 % of U.S. patents granted to Canadian biotech firms, with the companies Aventis Pasteur, NPS Allelix Pharmaceuticals, Hemosol, Visible Genetics, and Spectral Diagnostics ranking in Canada's top fivin Canada's top five.

One of the most important drivers of change in the pharmaceutical industry was a wave of patent expirations that really picked up steam in 2010.

As the pharmaceutical industry's blockbuster drugs fall off the patent cliff, with precious few drugs in the pipeline to replace them, there are signs that big pharma could turn more of its attention to biologically derived medicines.

The Plant Patent Act of 1930 pushed food science forward and helped power agribusiness into the second most gainful enterprise in the nation (after pharmaceuticals).

In order to promote their patented drugs and vaccines against flu, pharmaceutical companies have influenced scientists and official agencies, responsible for public health standards, to alarm governments worldwide.

However, I used the time to get a job with a big German pharmaceutical company, where I've been working in the patent department, dealing mainly with biotechnology patents and communicating with patent offices and attorneys all over the world.

Elan Pharmaceuticals in South San Francisco has a patent on another molecule, which is apparently different from Amgen's, and pharmaceutical giant SmithKline Beecham is known to have yet another candidate.

Of the three leaders in U.S. Patent and Trademark Office patents, U.S. and EU inventions are concentrated in chemistry and health, including pharmaceuticals and biotechnology.

Considerations about patenting and intellectual property exist in industry, although the same is true for academia these days, says Alan Goldhammer, vice president of scientific and regulatory affairs for Pharmaceutical Research and Manufacturers of America (PhRMA), an organization that represents the country's leading pharmaceutical research and biotech companies.

According to Lisa Conte, founder of Shaman Pharmaceuticals, which supported the treaty even in Rio, the new interpretation «gave those companies the confidence that if they are working in these countries they will have patent protection».

The international patent law protecting new pharmaceutical entities was internally recognized in 1997, ending unauthorized copying and protecting research investments.

It lets pharmaceuticals companies claim extension of the life of a patent on a new drug, to compensate for the years lost in testing it for safety before sale.

* Eliminate «pay - for - delay» strategies in which a pharmaceutical company with a brand name drug shares profits on that drug with a generic drug manufacturer for the remainder of a patent period, effectively eliminating a patent challenge and competition.

The test called SkimuneTM, which is trademarked and has a patent pending, has been successfully tested by a number of large pharmaceutical companies on drugs in development and provides a reliable result within two weeks.

«That level of proof is never going to be forthcoming in the current environment because it requires doing a really extensive clinical trial series, and given that a pharmaceutical company can't patent whole plant marijuana, it's in no company's interest to do that.»

The draft makes clear that the three panelists would like to see a reduction in the 5 - year extensions granted on pharmaceutical patents about to expire.

Fourteen members of the council's Parliamentary Assembly have released a document charging that «pharmaceutical companies have influenced scientists and official agencies... to alarm governments» in order to «promote their patented drugs and vaccines».

Choosing London to host the court specializing in life sciences patents plays to Britain's strength in pharmaceutical research, says Richard Jennings, deputy director of Cambridge Enterprise, a company that helps commercialize inventions at the University of Cambridge in the United Kingdom (U.K.).

Plomer, professor of law and bioethics at the University of Sheffield in the UK, highlights the tension between patents on scientific discoveries such as isolated genes and pharmaceutical drugs and universal access to science.

These patents have led to a number of licenses to pharmaceutical, chemical and biotechnology companies, and a number of products that have been commercialized or are in clinical development.

The newly issued patents (U.S. Patent Nos. 9493515 and 9493516) broadly cover Proclara's core technology, including methods of treating protein misfolding diseases and pharmaceutical compositions comprising the company's lead molecule, NPT088, a GAIM - Ig fusion protein currently being evaluated in a Phase 1b study for the treatment of Alzheimer's disease.

Since that post, there have been exciting developments in the progress of the two most advanced of these immunotherapies: PD01A, the AS - targeting active vaccine from Austrian biotechnology startup AFFiRiS AG, developed using its patented «AFFITOME» neo-antigen discovery platform of molecular mimicry; and PRX002, a humanized monoclonal Ab (mAb) under development from Prothena Corp PLC, the successor of aggregate - clearing immunotherapy pioneer Élan Pharmaceuticals.

The pharmaceutical companies can not patent any natural plant chemicals, however chemicals that are altered in molecular structure can be patented.

With the rise of antibiotic resistant pathogens, researchers are turning their attention to natural products in hopes of finding cures outside of the patented pharmaceutical paradigm for fighting disease.

However, since a diet can not be patented, mainstream medicine has instead focused on pharmaceutical drugs and vaccines to combat diseases like Alzheimer's, as such drugs are seen as a financial windfall for pharmaceutical companies, with so many Americans in the «Baby Boomer» age group entering into their senior years.